BVA-200 vs BVA-100 Validation Study
NCT06227819
Anemia, Cardiovascular Diseases
Oak Ridge, Tennessee, United States
View Trial DetailsNCT Number: NCT02444845
The purpose of this study is to evaluate the prevalence of CKD-related anemia at an early stage through screening of high-risk patients in Pakistan at the level of physicians, cardiologists, and diabetologists. The information gathered may serve as a foundation in formulating national guidelines for better early diagnosis and management of patients with CKD.
Looking for future studies?
Notify Me40 year and older
All sexes
Observational
Islamabad, Pakistan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Up to 12 months
Time frame: Up to 12 months
Hoffmann-La Roche
Industry
Prevalence of Anaemia Secondary to Early Stage Chronic Kidney Disease in High Risk Diabetic and/or Hypertensive Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06227819
Anemia, Cardiovascular Diseases
Oak Ridge, Tennessee, United States
View Trial DetailsNCT04037436
Arthritis, Bone Diseases
Cambridge, Ontario, Canada
View Trial DetailsNCT04663685
Arthritis, Behavior
Waterloo, Canada
View Trial DetailsNCT02587936
Bronchial Diseases, Bronchiolitis
Farmington, Connecticut, United States
View Trial Details